Oct 2, 2024

Featuring perspectives from Dr Joshua K Sabari and Dr Helena Yu, including the following topics:

• Introduction: Checkpoint Inhibitors and Lung Cancer with an EGFR Mutation (0:00)
• Current Management of Metastatic Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations — Dr Sabari (5:39)
• Novel Therapeutic Approaches for...

Sep 12, 2024

Featuring slide presentations and related discussion from Dr Pasi A Jänne, Prof Tom John, Dr Zofia Piotrowska and Dr Alexander I Spira, including the following topics:

• Recent Advances in the Management of Localized and Locally Advanced Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation — Prof John (0:00)

Aug 21, 2024

Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer | Faculty Presentation 1: Significance of Biomarker Testing in Localized Non-Small Cell Lung Cancer (NSCLC) and Historical Management Paradigm for ALK-Positive Disease — Professor Solange Peters, MD, PhD

CME...

Aug 21, 2024

Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer | Faculty Presentation 2: Emerging Role and Practical Application of ALK-Targeted Therapy in Localized NSCLC — Professor Ben Solomon, MBBS, PhD

CME information and select...

Aug 21, 2024

Featuring perspectives from Prof Solange Peters and Prof Ben Solomon, including the following topics:

• Introduction (0:00)
• Significance of Biomarker Testing in Localized Non-Small Cell Lung Cancer (NSCLC) and Historical Management Paradigm for ALK-Positive Disease — Prof Peters (9:17)
• Emerging Role and Practical...